Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2012
05/17/2012US20120123126 Compounds As c-Met Kinase Inhibitors
05/17/2012US20120123125 Manufacturing process for tiotropium bromide
05/17/2012US20120123109 Luminescence quenching compounds
05/17/2012US20120122931 Indole derivative or pharmaceutically acceptable salt thereof
05/17/2012US20120122926 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122880 Thioxanthene derivatives for the treatment of infectious diseases
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122862 Arginine derivatives with np-i antagonistic activity
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122849 Pkm2 modulators for use in the treatment of cancer
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122708 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for the identification of biological and pharmacological activity
05/17/2012US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2453496A1 Organic electroluminescent element, novel compound, lighting device and display device
05/16/2012EP2451807A1 Cyclic triazo sodium channel blockers
05/16/2012EP2451806A2 Cyclic triazo sodium channel blockers
05/16/2012EP2451803A2 Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
05/16/2012EP2451799A1 Novel microbiocides
05/16/2012EP2451795A1 Compositions and methods for enhancing virus efficacy
05/16/2012EP2451782A1 Dual-acting pyrazole antihypertensive agents
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012CN1931827B 2- and 2,5-substituted phenylketo-enols
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/16/2012CN102459245A Thioxanthene derivatives for the treatment of infectious diseases
05/16/2012CN102459244A 喹唑啉二酮衍生物、其制备及其多种治疗用途 Quinazoline dione derivatives, their preparation and their therapeutic uses multiple
05/16/2012CN102459240A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459234A 作为p70s6激酶抑制剂的取代的苯并三嗪类和喹喔啉类 As the substituted benzo triazines and quinoxaline p70s6 kinase inhibitor
05/16/2012CN102459230A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459228A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459223A 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
05/16/2012CN102459221A 噻吩衍生物 Thiophene derivative
05/16/2012CN102459215A 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102453027A Organic compound and organic electroluminescent device employing the same
05/16/2012CN102453026A C-aryl glucoside derivative, preparation method and application thereof
05/16/2012CN102452974A Organic light-emitting device
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178528 Histamine H3 receptor agents, preparation and therapeutic uses
05/15/2012US8178510 Preparation of thioarabinofuranosyl compounds and use thereof
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012WO2012061698A2 Compounds useful as modulators of trpm8
05/10/2012WO2012060234A1 Xanthone compound and organic light-emitting device including the same
05/10/2012WO2012059932A1 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
05/10/2012WO2012059497A1 N-hetarylmethyl pyrazolylcarboxamides
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012WO2012037309A3 Improved process for the preparation of sufentanil base and related compounds
05/10/2012WO2012017021A3 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/10/2012US20120116084 N-type organic semiconductors including at least two 2-dicyanomethylene-3-cyano-2,5-dihydrofuran groups
05/10/2012US20120115915 N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
05/10/2012US20120115909 Tazarotene derivatives
05/10/2012US20120115906 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
05/10/2012US20120115885 Quinolinone PDE2 Inhibitors
05/10/2012US20120115883 Pyrimidine derivatives which are antagonists of the vitronectin receptor
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115820 Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
05/10/2012US20120114765 Anti-neoplastic compounds, compositions and methods
05/10/2012US20120114696 Small-molecule botulinum toxin inhibitors
05/10/2012US20120112174 Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode
05/10/2012US20120112169 Aromatic amine derivative, and organic electroluminescent element comprising same
05/10/2012DE102011084120A1 Photovoltaische Vorrichtung A photovoltaic device
05/10/2012CA2815117A1 N-hetarylmethyl pyrazolylcarboxamides
05/09/2012EP2450975A2 Compound for organic optoelectronic device and organic light emitting diode including the same
05/09/2012EP2450356A1 Carbazole and anthracene moiety containing light-emitting device material and light-emitting devices
05/09/2012EP2448927A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
05/09/2012EP2448582A1 Therapeutic compounds and compositions
05/09/2012EP2324008B1 3,4-diarylpyrazoles as protein kinase inhibitors
05/09/2012EP2287162B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
05/09/2012EP2287161B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012CN102448952A Antiviral compounds and uses thereof
05/09/2012CN102448951A Therapeutic compositions and related methods of use
05/09/2012CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier
05/09/2012CN102448946A Materials for organic electroluminescent devices
05/09/2012CN102448940A Pharmaceutical composition for treating or preventing glaucoma
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448920A Antiviral compounds and uses thereof
05/09/2012CN102442999A Photochromic pyrimidine-thiophene mixed octafluorocyclopentene compound, synthesis method and application thereof
05/09/2012CN102442973A Method for closed-loop synthesis of benzoglioxaline and benzothiazole compounds by catalytic oxidation of primary alcohol
05/09/2012CN101619040B Aporphine compound, medicinal composition thereof and application thereof
05/09/2012CN101560191B Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
05/09/2012CN101213195B Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
05/08/2012US8173693 Benzenesulfonamide derivatives and pharmaceutical composition thereof
05/08/2012US8173682 Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173646 FAB I inhibitors
05/03/2012WO2012058529A2 Metalloenzyme inhibitor compounds
05/03/2012WO2012055169A1 C-arylglucoside derivative, preparation method therefor, and use thereof
05/03/2012WO2011162515A3 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
05/03/2012WO2011107608A8 Heterocyclic amides as rock inhibitors
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 523